Cardiff Oncology (CRDF) Institutional Ownership $2.08 -0.09 (-3.92%) As of 03:42 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Cardiff Oncology (NASDAQ:CRDF)CurrentInstitutional OwnershipPercentage16.29%Number ofInstitutional Buyers(last 12 months)68TotalInstitutional Inflows(last 12 months)$46.14MNumber ofInstitutional Sellers(last 12 months)21TotalInstitutional Outflows(last 12 months)$9.39M Get CRDF Insider Trade Alerts Want to know when executives and insiders are buying or selling Cardiff Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CRDF Institutional Buying and Selling by Quarter Cardiff Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Engineers Gate Manager LP13,585$43K0.0%N/A0.020% 8/15/2025 BNP Paribas Financial Markets15,437$49K0.0%+335.1%0.023% 8/15/2025 Bank of America Corp DE93,393$294K0.0%+189.3%0.140% 8/15/2025 Acorn Capital Advisors LLC1,408,767$4.44M2.9%-2.3%2.117% 8/15/2025 Adage Capital Partners GP L.L.C.1,423,000$4.48M0.0%-1.5%2.139% 8/14/2025 Glenview Trust co43,128$136K0.0%+79.9%0.065% 8/14/2025 The Manufacturers Life Insurance Company 21,956$69K0.0%+23.9%0.033% 8/13/2025 Marshall Wace LLP298,715$941K0.0%-26.1%0.449% 8/13/2025 Invesco Ltd.23,795$75K0.0%+24.9%0.036% 8/13/2025 Lido Advisors LLC15,000$47K0.0%N/A0.023% Get the Latest News and Ratings for CRDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. 8/13/2025 Quadrature Capital Ltd23,117$73K0.0%N/A0.035% 8/12/2025 XTX Topco Ltd130,352$411K0.0%N/A0.196% 8/12/2025 Rhumbline Advisers84,759$267K0.0%+34.2%0.127% 8/12/2025 AlphaCore Capital LLC101,575$320K0.0%N/A0.153% 8/12/2025 MAI Capital Management505,197$1.59M0.0%-46.2%0.759% 8/8/2025 Creative Planning34,050$107K0.0%-48.7%0.051% 8/8/2025 Geode Capital Management LLC1,498,838$4.72M0.0%+7.5%2.253% 8/7/2025 Los Angeles Capital Management LLC24,655$78K0.0%N/A0.037% 8/4/2025 Integrity Alliance LLC.12,860$41K0.0%N/A0.019% 7/24/2025 Blair William & Co. IL2,524,118$7.95M0.0%+44.1%3.794% 7/23/2025 SteelPeak Wealth LLC22,800$72K0.0%+23.2%0.034% 7/10/2025 Baader Bank Aktiengesellschaft10,022$32K0.0%N/A0.015% 6/27/2025 Goldman Sachs Group Inc.107,133$336K0.0%-30.0%0.161% 5/29/2025 Rhumbline Advisers63,142$198K0.0%+18.8%0.095% 5/20/2025 Belpointe Asset Management LLC11,640$37K0.0%N/A0.017% 5/16/2025 Goldman Sachs Group Inc.107,133$336K0.0%-30.0%0.161% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.34,319$108K0.0%+50.4%0.052% 5/16/2025 Jacobs Levy Equity Management Inc.396,118$1.24M0.0%+183.2%0.595% 5/16/2025 AQR Capital Management LLC29,183$92K0.0%-28.2%0.044% 5/16/2025 Adage Capital Partners GP L.L.C.1,445,000$4.54M0.0%+11.8%2.172% 5/15/2025 MAI Capital Management939,593$2.95M0.0%+2.5%1.412% 5/15/2025 DAFNA Capital Management LLC150,000$471K0.1%N/A0.225% 5/14/2025 Corebridge Financial Inc.28,555$90K0.0%+40.8%0.043% 5/14/2025 MetLife Investment Management LLC35,726$112K0.0%+34.5%0.054% 5/12/2025 Nuveen LLC857,570$2.69M0.0%N/A1.289% 5/12/2025 Virtu Financial LLC19,212$60K0.0%-62.5%0.029% 5/9/2025 Charles Schwab Investment Management Inc.169,974$534K0.0%+67.2%0.256% 5/9/2025 Blair William & Co. IL1,751,274$5.50M0.0%+521.0%2.632% 5/8/2025 GSA Capital Partners LLP354,557$1.11M0.1%-6.7%0.533% 5/7/2025 Dauntless Investment Group LLC96,208$302K0.4%N/A0.145% When the levee breaks (Ad)The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point. In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks.Click here to watch the urgent broadcast and get ahead of what’s coming.4/29/2025 Bank of New York Mellon Corp323,347$1.02M0.0%+12.0%0.486% 4/28/2025 Ledgewood Wealth Advisors LLC11,190$35K0.0%N/A0.017% 4/22/2025 Castleview Partners LLC14,465$45K0.0%N/A0.022% 4/17/2025 Brighton Jones LLC16,500$52K0.0%N/A0.025% 4/14/2025 Yarbrough Capital LLC88,163$277K0.0%N/A0.133% 4/8/2025 Rhumbline Advisers63,142$198K0.0%+18.8%0.095% 2/19/2025Invst LLC36,000$156K0.0%+60.0%0.070% 2/19/2025 Parr Mcknight Wealth Management Group LLC16,000$69K0.0%N/A0.031% 2/18/2025 AWM Investment Company Inc.106,435$462K0.1%N/A0.208% 2/17/2025 Two Sigma Advisers LP14,800$64K0.0%-95.5%0.029% 2/17/2025 Two Sigma Investments LP105,227$457K0.0%-43.0%0.206% 2/17/2025 Shay Capital LLC20,862$91K0.0%N/A0.041% 2/17/2025 Point72 Asset Management L.P.508,438$2.21M0.0%N/A0.994% 2/17/2025 ProShare Advisors LLC11,486$50K0.0%N/A0.022% 2/17/2025Nuveen Asset Management LLC586,616$2.55M0.0%+73.7%1.147% 2/17/2025 Orbimed Advisors LLC1,538,462$6.68M0.1%N/A3.009% 2/17/2025 Millennium Management LLC440,944$1.91M0.0%+188.8%0.862% 2/17/2025 Laurion Capital Management LP576,924$2.50M0.0%N/A1.128% 2/17/2025 J. Goldman & Co LP47,250$205K0.0%N/A0.092% 2/17/2025 Jacobs Levy Equity Management Inc.139,854$607K0.0%N/A0.274% 2/17/2025 Deutsche Bank AG49,566$215K0.0%N/A0.097% 2/17/2025 Blackstone Inc.41,700$181K0.0%N/A0.082% 2/17/2025 Caxton Corp13,287$58K0.3%N/A0.026% 2/17/2025 Bank of America Corp DE34,012$148K0.0%-25.0%0.067% 2/17/2025 BNP Paribas Financial Markets5,733$25K0.0%N/A0.011% 2/17/2025 Acorn Capital Advisors LLC1,442,308$6.26M3.4%N/A2.821% 2/14/2025 Northern Trust Corp337,092$1.46M0.0%+8.9%0.659% 2/14/2025 The Manufacturers Life Insurance Company15,487$67K0.0%N/A0.030% 2/14/2025 Boothbay Fund Management LLC129,960$564K0.0%N/A0.254% 2/14/2025 Voya Investment Management LLC13,124$57K0.0%N/A0.026% 2/14/2025 Adage Capital Partners GP L.L.C.1,292,308$5.61M0.0%N/A2.527% 2/14/2025 Price T Rowe Associates Inc. MD15,390$67K0.0%-68.7%0.030% 2/14/2025 MetLife Investment Management LLC26,559$115K0.0%N/A0.052% 2/13/2025 Marshall Wace LLP62,600$272K0.0%-56.2%0.122% 2/13/2025 Elkhorn Partners Limited Partnership32,000$139K0.1%-28.9%0.063% 2/13/2025 XTX Topco Ltd40,763$177K0.0%-66.1%0.080% 2/13/2025 Mariner LLC14,047$61K0.0%N/A0.027% 2/13/2025 Barclays PLC62,596$272K0.0%+17.9%0.122% 2/13/2025 DRW Securities LLC23,474$102K0.0%N/A0.046% 2/13/2025 Raymond James Financial Inc.12,996$56K0.0%N/A0.025% 2/13/2025 Renaissance Technologies LLC483,090$2.10M0.0%-19.8%0.945% 2/13/2025 Wells Fargo & Company MN32,064$139K0.0%+38.1%0.063% 2/12/2025 Thoroughbred Financial Services LLC19,614$85K0.0%+43.8%0.038% 2/12/2025 Geode Capital Management LLC982,878$4.27M0.0%+5.9%1.922% 2/12/2025 Blair William & Co. IL282,025$1.22M0.0%+14.1%0.552% 2/11/2025 American Century Companies Inc.53,955$234K0.0%+12.8%0.106% 2/11/2025 Virtu Financial LLC51,181$222K0.0%N/A0.100% 2/11/2025 Intech Investment Management LLC18,266$79K0.0%N/A0.036% 2/10/2025 Glenview Trust co23,978$104K0.0%N/A0.047% 2/7/2025 HighTower Advisors LLC34,213$148K0.0%+123.1%0.067% “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late.2/6/2025 Raymond James Financial Inc.12,996$56K0.0%N/A0.025% 2/6/2025 Charles Schwab Investment Management Inc.101,664$441K0.0%-16.2%0.199% 2/4/2025 Bank of New York Mellon Corp288,615$1.25M0.0%+68.7%0.564% 2/3/2025Callan Capital LLC101,575$441K0.0%+11.1%0.199% 1/30/2025 Rhumbline Advisers53,172$231K0.0%+24.0%0.104% 1/17/2025 SG Americas Securities LLC17,834$77K0.0%-25.5%0.035% 1/15/2025 HB Wealth Management LLC24,500$105K0.0%N/A0.048% 1/14/2025 Assenagon Asset Management S.A.67,231$292K0.0%-75.1%0.131% 11/19/2024 Barclays PLC53,089$141K0.0%+291.9%0.104% 11/19/2024Invst LLC22,500$60K0.0%-37.5%0.044% (Data available from 1/1/2016 forward) CRDF Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CRDF shares? During the previous two years, 83 institutional investors and hedge funds held shares of Cardiff Oncology. The most heavily invested institutionals were Vanguard Group Inc. ($10.26M), Blair William & Co. IL ($7.95M), Orbimed Advisors LLC ($6.68M), Geode Capital Management LLC ($4.72M), Adage Capital Partners GP L.L.C. ($4.48M), Acorn Capital Advisors LLC ($4.44M), and Nuveen LLC ($2.69M).Learn more on Cardiff Oncology's institutional investors. What percentage of Cardiff Oncology's stock is owned by institutional investors? 16.29% of Cardiff Oncology's stock is owned by institutional investors. Learn more on CRDF's institutional investor holdings. Which institutional investors have been buying Cardiff Oncology's stock? Of the 74 institutional investors that purchased Cardiff Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Blair William & Co. IL ($2.37M), Orbimed Advisors LLC ($1.54M), Adage Capital Partners GP L.L.C. ($1.45M), Acorn Capital Advisors LLC ($1.44M), Assenagon Asset Management S.A. ($1.22M), Nuveen LLC ($857.57K), and Laurion Capital Management LP ($576.92K). How much institutional buying is happening at Cardiff Oncology? Institutional investors have bought a total of 12,069,031 shares in the last 24 months. This purchase volume represents approximately $46.14M in transactions. Which of Cardiff Oncology's major shareholders have been selling company stock? Of the 21 institutional investors that sold Cardiff Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Assenagon Asset Management S.A. ($1.15M), MAI Capital Management ($434.40K), Two Sigma Advisers LP ($316.40K), Marshall Wace LLP ($186.02K), Renaissance Technologies LLC ($119.29K), Goldman Sachs Group Inc. ($91.80K), and XTX Topco Ltd ($79.62K). How much institutional selling is happening at Cardiff Oncology? Institutional investors have sold a total of 2,773,325 shares in the last 24 months. This volume of shares sold represents approximately $9.39M in transactions. Related Companies ABUS Institutional Ownership KALV Institutional Ownership KURA Institutional Ownership BCAX Institutional Ownership TSHA Institutional Ownership VIR Institutional Ownership TERN Institutional Ownership RLAY Institutional Ownership SIGA Institutional Ownership ORGO Institutional Ownership This page (NASDAQ:CRDF) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiff Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiff Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access